Clincosm LogoSign in Get a demo

Chronic Myeloid Leukemia, Chronic Phase

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ponatinib in CML Patients in Chronic Phase

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Therapeutic drug monitoring
  • Molecular Response
  • Cagliari, Italy
  • +4 more
Nov 3, 2023

Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    Jan 17, 2023

    Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Dasatinib Pill
    • Ketoconazole Pill
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr. José Eleuterio González
    Nov 25, 2022

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Withdrawal;Drug
      • Imatinib withdrawal
      • +2 more
      • Brno, Czechia
      • +7 more
      Aug 24, 2022

      Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

      Recruiting
      • Olverembatinib
      • +2 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Jul 26, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • +3 more
      • Augusta, Georgia
      • +1 more
      Jul 14, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Nilotinib
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Mar 15, 2022

      Flumatinib, Chronic Myeloid Leukemia, Chronic Phase, Imatinib Trial in Shenzhen (Flumatinib)

      Recruiting
      • Flumatinib
      • +2 more
      • Shenzhen, Guangdong, China
        The Second People's Hospital of Shenzhen
      Mar 15, 2022

      Chronic Myeloid Leukemia, Chronic Phase Trial in Spain (Ponatinib 15 MG, Acetylsalicylic acid 100 MG)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Ponatinib 15 MG
      • Acetylsalicylic acid 100 MG
      • L'Hospitalet De Llobregat, Barcelona, Spain
      • +12 more
      Feb 8, 2022

      Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Beijing, China
        Peking University People's Hospital(北京大学人民医院)
      Jan 3, 2022

      Chronic Myeloid Leukemia, Chronic Phase, CML, Chronic Phase, CML, Refractory Trial in Worldwide (Radotinib HCl)

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • +3 more
      • Radotinib HCl
      • Uijeongbu-si, Gyeonggi-do, Korea, Republic of
      • +17 more
      Jan 3, 2022

      Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (HQP1351)

      Completed
      • Chronic Myeloid Leukemia, Chronic Phase
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jan 19, 2020

      Chronic Myeloid Leukemia, Chronic Phase Trial (Nilotinib)

      Completed
      • Chronic Myeloid Leukemia, Chronic Phase
      • (no location specified)
      Nov 1, 2017

      Cemivil® (Imatinib) in Chronic Myeloid Leukemia Jordan

      Completed
      • Chronic Myeloid Leukemia, Chronic Phase
      • Amman, Jordan
      • +2 more
      Nov 29, 2016